More information is emerging in the Chinese authorities' case against British pharmaceutical company GlaxoSmithKline (GSK). To bring you up to speed: the New York Times reported Monday that "high-ranking executives at the company’s China operations used travel agencies as money-laundering shops to funnel bribes to doctors, hospitals, medical associations, foundations and government officials." So much money was being funneled that local travel agencies "would compete for the chance to take part." Four GSK executives -- all Chinese nationals -- were detained.
